首页> 外国专利> TREATMENT FOR BLADDER DYSFUNCTION USING LIPOSOMAL BOTULINUM TOXIN

TREATMENT FOR BLADDER DYSFUNCTION USING LIPOSOMAL BOTULINUM TOXIN

机译:脂质体肉毒杆菌毒素治疗膀胱功能障碍

摘要

PROBLEM TO BE SOLVED: To provide treatment for bladder dysfunction using liposomal botulinum toxin.SOLUTION: Liposomes are used for intravesical drug delivery, especially delivery of botulinum toxin (BoNT) to help improve lower urinary tract symptoms by decreasing bladder irritation and frequency. The system uses a lower and safer dose of BoNT with lower risk of urinary retention. A simple instillation of liposome-BoNT as a liquid formulation into the bladder, in a typical volume of 30-60 ml, will achieve efficacy similar to that currently achieved with cystoscopic needle injection of BoNT. The dose may be lower than that done by injection, thereby causing significantly less risk of urinary retention. Liposome-BoNT can protect the BoNT from bladder and urine breakdown.
机译:解决的问题:使用脂质体肉毒杆菌毒素为膀胱功能障碍提供治疗。解决方案:脂质体用于膀胱内药物输送,尤其是肉毒杆菌毒素(BoNT)的输送,可通过降低膀胱刺激性和频率来帮助改善下尿路症状。该系统使用较低剂量和更安全的BoNT剂量,并降低尿retention留的风险。将脂质体-BoNT的液体制剂以30-60 ml的典型体积简单地滴注到膀胱中,将获得与目前用BoNT的膀胱镜针头注射获得的功效相似的功效。该剂量可以低于注射剂量,因此引起尿retention留的风险大大降低。脂质体-BoNT可以保护BoNT免受膀胱和尿液的破坏。

著录项

  • 公开/公告号JP2014062125A

    专利类型

  • 公开/公告日2014-04-10

    原文格式PDF

  • 申请/专利权人 LIPELLA PHARMACEUTICALS INC;

    申请/专利号JP20140000235

  • 发明设计人 CHANCELLOR MICHAEL B;JONATHAN H KAUFMAN;

    申请日2014-01-06

  • 分类号A61K38;A61P13/12;A61K9/127;A61K47/10;A61K47/24;A61K9/19;

  • 国家 JP

  • 入库时间 2022-08-21 16:17:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号